No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human S100A14 Antibodies:
anti-Mouse (Murine) S100A14 Antibodies:
anti-Rat (Rattus) S100A14 Antibodies:
Go to our pre-filtered search.
S100A14 increases the motility of lung adenocarcinoma cells, and might be a diagnostic and prognostic serum biomarker and potential therapeutic target for lung adenocarcinoma.
S100A14 is expressed in a subset of lung adenocarcinoma, and its expression is related to certain clinicopathological parameters. Furthermore, S100A14 expression was strongly correlated with migration and invasion in lung adenocarcinoma cells.
Increased S100A15 expression and decreased DNA methylation of its gene promoter region were associated with high metastasis potential and poor outcome in lung adenocarcinoma.
results indicate that S100A14 may have a role in the induction of differentiation and inhibition of cell metastasis in gastric cancer.
We identified a two-gene signature including KCNN4 and S100A14 which was related to recurrence in optimally debulked serous ovarian carcinoma patients
Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion
The antimicrobial peptides psoriasin (S100A7) and koebnerisin (S100A15) suppress extracellular matrix production and proliferation of human fibroblasts
S100A14 is expressed in epithelial-like, but not in mesenchymal-like, triple-negative breast cancer cells in vitro.
Data show that the genetic variant 425G>A on the 5'-UTR of calcium-binding protein S100A14 was associated with reduced S100A14 expression in gastric cancer (GC) cells.
Data indicate that S100A14 has a crucial role in EOC progression, and its overexpression is associated with poor prognosis.
Data demonstrate that S100A14 is transcriptionally regulated by JunB and involved in esophageal squamous cell carcinoma cell differentiation.
S100A14 interacts with S100A16 and regulates its expression in human cancer cells.
Data show that S100A14 and HER2 are colocalized in plasma membrane of breast cancer tissue cells and breast cancer cell lines.
High S100A14 expression is associated with metastasis of hepatocellular carcinoma.
The solution structure of homodimeric S100A14 in the apo state solved by NMR
that S100A14 promotes cell motility and invasiveness by regulating the expression and function of MMP2 in a p53-dependent manner.
S100A14 provides a novel role in oral squamous cell carcinoma cell proliferation by inducing G1-arrest
S100A14 induces cell apoptosis is partially in a RAGE-dependent manner
S100A14 and S100A4 have roles in metastasis in colorectal cancer after surgery
Data constitute strong evidence in support of the notion that S100A14 might function as a cancer suppressor working in the P53 pathway and play a role in esophageal carcinogenesis.
This gene encodes a member of the S100 protein family which contains an EF-hand motif and binds calcium. The gene is located in a cluster of S100 genes on chromosome 1. Levels of the encoded protein have been found to be lower in cancerous tissue and associated with metastasis suggesting a tumor suppressor function (PMID: 19956863, 19351828).
S100 calcium-binding protein A14
, breast cancer membrane protein 84
, protein S100-A14
, S100 calcium binding protein A15
, S100 calcium binding protein A14